InCrowd Novel Coronavirus (COVID-19) Patient Tracking Report – Wave 3

As the novel coronavirus (COVID-19) pandemic continues to develop in the US, InCrowd wanted to understand how the experiences, perceptions, and predictions of patients who are immunocompromised or have chronic conditions have evolved over the course of this crisis.

We’d like to thank our friends at Rare Patient Voice for their help in sourcing this important research.

Methodology:

• Method:
  • 10-Minute MicroSurvey via InCrowd
• Crowds:
  • Patients with Mild to Severe Illnesses
• Sample Size:
  • 152 Total Patients (Previous Waves: 159, 152)
    • 84 Mild to Moderate Patients (Previous Wave: 83, 77)
    • 68 Moderate to Severe Patients (Previous Wave: 76, 75)
• Fielding Period:
  • October 7th – 8th

InCrowd’s other COVID-19 Tracking Reports:

• COVID-19 Vaccine Development Report – Wave 2
• Physician Tracking Report – Wave 6
• Non-Frontline Specialist Tracking Report – Wave 2
• Treatment & Outcomes of Diabetes Patients During the COVID-19 Pandemic
• Telemedicine & Remote-Patient Monitoring Report